Gossamer Bio, Inc.
GOSS
$1.08
-$0.015-1.38%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.23% | -162.57% | 217.42% | 12.92% | -20.35% |
| Total Depreciation and Amortization | -2.09% | 10.69% | 0.61% | -1.99% | -7.54% |
| Total Amortization of Deferred Charges | 1.71% | -27.10% | 9.56% | -4.87% | -4.64% |
| Total Other Non-Cash Items | 19.95% | -25.85% | -34.81% | -75.26% | 209.24% |
| Change in Net Operating Assets | -37.03% | -106.35% | 533.01% | -1,634.69% | 1,146.75% |
| Cash from Operations | -10.76% | -127.53% | 322.45% | -56.48% | 3.10% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 298.91% | 54.74% | -195.85% | 529.30% | 87.85% |
| Cash from Investing | 298.91% | 54.74% | -195.85% | 529.30% | 87.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -233.38% | 0.00% | 0.00% |
| Issuance of Common Stock | -100.00% | -- | -100.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Financing | -100.00% | 103.05% | -260.63% | 11.99% | -101.46% |
| Foreign Exchange rate Adjustments | -234.41% | 1,262.50% | 87.10% | -132.12% | 241.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 130.15% | -221.66% | 610.90% | 113.37% | -210.73% |